Wockhardt Raids Competitors To Deal With Quality-Production Problems
This article was originally published in PharmAsia News
Executive Summary
Wockhardt has responded to a series of largely U.S. FDA actions potentially crippling its ability to sell into the vital U.S. market by replacing much of its management with people attracted from India competitors.